These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9689163)
1. Accumulation of Nsigma-(carboxy-methyl)lysine and changes in glomerular extracellular matrix components in Otsuka Long-Evans Tokushima fatty rat: a model of spontaneous NIDDM. Kushiro M; Shikata K; Sugimoto H; Ikeda K; Horiuchi S; Makino H Nephron; 1998 Aug; 79(4):458-68. PubMed ID: 9689163 [TBL] [Abstract][Full Text] [Related]
2. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats. Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956 [TBL] [Abstract][Full Text] [Related]
3. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats. Okada M; Takemura T; Yanagida H; Yoshioka K Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945 [TBL] [Abstract][Full Text] [Related]
5. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats. Furuse Y; Hashimoto N; Maekawa M; Toyama Y; Nakao A; Iwamoto I; Sakurai K; Suzuki Y; Yagui K; Yuasa S; Toshimori K; Saito Y Nephron Exp Nephrol; 2004; 98(3):e100-8. PubMed ID: 15528945 [TBL] [Abstract][Full Text] [Related]
6. Different effects of castration and estrogen administration on glomerular injury in spontaneously hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Tomiyoshi Y; Sakemi T; Aoki S; Miyazono M Nephron; 2002 Dec; 92(4):860-7. PubMed ID: 12399633 [TBL] [Abstract][Full Text] [Related]
8. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Yagi K; Kim S; Wanibuchi H; Yamashita T; Yamamura Y; Iwao H Hypertension; 1997 Mar; 29(3):728-35. PubMed ID: 9052888 [TBL] [Abstract][Full Text] [Related]
10. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus. Yamabe N; Yokozawa T J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372 [TBL] [Abstract][Full Text] [Related]
11. Diffuse glomerular nodular lesions in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha, an inheritant diabetic gene in humans. Hara S; Umeyama K; Yokoo T; Nagashima H; Nagata M PLoS One; 2014; 9(3):e92219. PubMed ID: 24647409 [TBL] [Abstract][Full Text] [Related]
12. Role of TGF-beta1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Yoshikawa H; Kihara Y; Taguchi M; Yamaguchi T; Nakamura H; Otsuki M Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G549-58. PubMed ID: 11842006 [TBL] [Abstract][Full Text] [Related]
13. CS-886, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats. Koga K; Yamagishi S; Takeuchi M; Inagaki Y; Amano S; Okamoto T; Saga T; Makita Z; Yoshizuka M Mol Med; 2002 Oct; 8(10):591-9. PubMed ID: 12477969 [TBL] [Abstract][Full Text] [Related]
14. Glomerular extracellular matrix and growth factors in diffuse mesangial sclerosis. Yang Y; Zhang SY; Sich M; Béziau A; van den Heuvel LP; Gubler MC Pediatr Nephrol; 2001 May; 16(5):429-38. PubMed ID: 11405118 [TBL] [Abstract][Full Text] [Related]
15. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Pugliese G; Pricci F; Pesce C; Romeo G; Lenti E; Caltabiano V; Vetri M; Purrello F; Di Mario U Diabetes; 1997 Jul; 46(7):1198-206. PubMed ID: 9200656 [TBL] [Abstract][Full Text] [Related]
16. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats. Kang YS; Ko GJ; Lee MH; Song HK; Han SY; Han KH; Kim HK; Han JY; Cha DR Nephrol Dial Transplant; 2009 Jan; 24(1):73-84. PubMed ID: 18682491 [TBL] [Abstract][Full Text] [Related]
18. Apoptotic cell loss following cell proliferation in renal glomeruli of Otsuka Long-Evans Tokushima Fatty rats, a model of human type 2 diabetes. Murata I; Takemura G; Asano K; Sano H; Fujisawa K; Kagawa T; Baba K; Maruyama R; Minatoguchi S; Fujiwara T; Fujiwara H Am J Nephrol; 2002; 22(5-6):587-95. PubMed ID: 12381965 [TBL] [Abstract][Full Text] [Related]
19. Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta(1) expression in spontaneously diabetic (OLETF) rats. Aoyama I; Shimokata K; Niwa T Am J Nephrol; 2000; 20(3):232-41. PubMed ID: 10878408 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. Fukuzawa Y; Watanabe Y; Inaguma D; Hotta N J Lab Clin Med; 1996 Dec; 128(6):568-78. PubMed ID: 8960640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]